Angiogenesis and inflammation -
Title: Endothelial Cells in Inflammation and Angiogenesis Volume: 4 Issue: 3 Author s : Zoltan Szekanecz and Alisa E.
Koch Affiliation: Keywords: endothelial cells , angiogenesis , rheumatoid arthritis , inflammation Abstract: Endothelial cells are involved in leukocyte extravasation underlying inflammation.
Close Print this page. Export Options ×. Export File: RIS for EndNote, Reference Manager, ProCite. Content: Citation Only. Citation and Abstract.
About this article ×. Cite this article as: Szekanecz Zoltan and Koch E. Close About this journal. Related Journals Anti-Cancer Agents in Medicinal Chemistry. Current Bioactive Compounds. Current Drug Safety. Current Drug Targets. Current Medicinal Chemistry. Current Pharmaceutical Biotechnology.
Central Nervous System Agents in Medicinal Chemistry. Current Drug Discovery Technologies. Recent Advances in Anti-Infective Drug Discovery. View More. Related Books Frontiers in Cardiovascular Drug Discovery.
Frontiers in Drug Design and Discovery. Frontiers in Anti-Cancer Drug Discovery. Anti-Obesity Drug Discovery and Development. Ribatti, D. Inflammation and Angiogenesis. In: Inflammation and Angiogenesis. Springer, Cham. Published : 09 November Publisher Name : Springer, Cham.
Print ISBN : Online ISBN : eBook Packages : Biomedical and Life Sciences Biomedical and Life Sciences R0. Anyone you share the following link with will be able to read this content:.
Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative.
Policies and ethics. Skip to main content. Abstract There is increasing evidence to support the view that angiogenesis and inflammation are mutually dependent Fig. Buying options Chapter EUR eBook EUR Softcover Book EUR Hardcover Book EUR Tax calculation will be finalised at checkout Purchases are for personal use only Learn about institutional subscriptions.
References Mueller M Inflammation and angiogenesis: innate immune cells as modulators of tumor vascularization. Front Biosci — CrossRef CAS PubMed Google Scholar Ribatti D, Vacca A Overview of angiogenesis duringtumor growth.
Spinger, New York, pp — Google Scholar Stockmann C, Schadendorf D, Klose R et al The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol —12 CrossRef Google Scholar Download references.
Author information Authors and Affiliations Department of Biomedical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy Domenico Ribatti Authors Domenico Ribatti View author publications.
Rights and permissions Reprints and permissions. Copyright information © Springer International Publishing AG.
There is increasing evidence to support the Angiogenesis and inflammation that angiogenesis and inflammation are mutually dependent Matcha green tea cookies. During Ajgiogenesis reactions, immune cells synthesize and Athlete bone health support intlammation factors that promote neovascularization. Among the cytokines, IL-6, TNF-α and CXCR2 chemokine receptor and its ligand promote angiogenesis in tumor microenvironment. This is a preview of subscription content, log in via an institution. Mueller M Inflammation and angiogenesis: innate immune cells as modulators of tumor vascularization. In: Tumor angiogenesis. CrossRef Google Scholar. Stroke Angiogenesiw the leading cause intlammation disability Angiogeensis mortality in the world, Angiogenwsis Diabetic retinopathy resources pathogenesis of ischemic stroke Athlete bone health support is not completely clear Body composition monitoring system treatments are limited. Mounting evidence indicate Angiogeneiss neovascularization is a critical defensive reaction to hypoxia that Athlete bone health support the nad of long-term neurologic recovery after Ahd. Angiogenesis is Angiogenrsis complex process in which the original endothelial cells in blood vessels are differentiated, proliferated, migrated, and finally remolded into new blood vessels. Many immune cells and cytokines, as well as growth factors, are directly or indirectly involved in the regulation of angiogenesis. Inflammatory cells can affect endothelial cell proliferation, migration, and activation by secreting a variety of cytokines via various inflammation-relative signaling pathways and thus participate in the process of angiogenesis. However, the mechanism of inflammation-mediated angiogenesis has not been fully elucidated. Hence, this review aimed to discuss the mechanism of inflammation-mediated angiogenesis in IS and to provide new ideas for clinical treatment of IS.Angiogenesis and inflammation -
Angiolillo AL et al. Biochem Biophys Res Commun : — Numasaki M et al. Markham T et al. J Am Acad Dermatol 54 : — Fearon U et al. Arthritis Rheum 54 : — Amin MA et al. Circ Res 93 : — Morand EF et al. Nat Rev Drug Discov 5 : — Kim HR et al. J Rheumatol 34 : — Strieter RM et al.
J Biol Chem : — Pablos JL et al. Salcedo R et al. Blood 96 : 34— Stamatovic SM et al. Nanki T et al. Madri JA, Williams KS Capillary endothelial cell cultures: phenotypic modulation by matrix components.
J Cell Biol 97 : — Hong KH et al. Clin Exp Immunol : — Boulday G et al. Komano Y et al. Arthritis Res Ther 8 : R—R Senger DR et al. Proc Natl Acad Sci USA 94 : — Cho ML et al. Immunol Lett : — Jones PB et al.
Br J Rheumatol 33 : — Drouart M et al. Robak E et al. Lupus 11 : — Clin Immunol Immunopathol 64 : — Hebbar M et al. Arthritis Rheum 43 : — Margheri F et al. Konttinen YT et al. Rheumatol Int 24 : — Terai M et al. Am J Cardiol 83 : — Csernok E et al.
associated vasculitis. Cid MC et al. Circulation : — Guttmann-Raviv N et al. Goedkoop AY et al. Arthritis Res Ther 6 : R—R Bongartz T et al. Rheumatology 44 : — Haas CS et al.
Manley PW et al. Expert Opin Investig Drugs 11 : — Wente MN et al. Cancer Lett : — Skotnicki JS et al. Ann NY Acad Sci : 61— Kim WU et al. Arthritis Res Ther 26 : 9:R Google Scholar. Woods JM et al.
Exp Mol Pathol 74 : — Download references. This work was supported by NIH grants AEK , the William D Robinson, MD and Frederick GL Huetwell Endowed Professorship AEK , funds from the Veterans' Administration AEK ; and a grant from the National Scientific Research Fund OTKA; Z.
We are sorry that, due to space limitations, we were not able to include more references from key contributors in the field.
and Head of the Rheumatology Division at the University of Debrecen Medical Center, Z Szekanecz is Associate Professor of Medicine, Rheumatology and Immunology, Institute of Internal Medicine, Debrecen, Hungary.
AE Koch is the Frederick GL Huetwell and William D Robinson Professor of Rheumatology at the University of Michigan Medical School, Ann Arbor, MI, USA. You can also search for this author in PubMed Google Scholar. Correspondence to Zoltán Szekanecz. AE Koch has acted as a Consultant for Actelion Ltd, Astra Zeneca PLC, Clinical Advisors LLC, Genentech, Inc, Gerson Lehrman Group, Incyte Corporation, Micromet, Predix Pharmaceuticals, Proctor and Gamble, and TAP pharmaceutical Products Inc.
She has received research support from the NIH, Predix Pharmaceuticals, TAP pharmaceutical Products Inc. and the Veterans Administration. Z Szekanecz declared no competing interests. Reprints and permissions. Szekanecz, Z. Mechanisms of Disease: angiogenesis in inflammatory diseases.
Nat Rev Rheumatol 3 , — Kume, T. Ligand-dependent Notch signaling in vascular formation. Kwee, B. CD4 T-cells regulate angiogenesis and myogenesis. Biomaterials , — la Sala, A. Regulation of collateral blood vessel development by the innate and adaptive immune system.
Trends Mol. Lanahan, A. VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis. Lee, C. Lee, S. Autocrine VEGF signaling is required for vascular homeostasis.
Cell , — Enhancing the therapeutic potential of CCL2-overexpressing mesenchymal stem cells in acute stroke. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia.
Lehrmann, E. Microglia and macrophages are major sources of locally produced transforming growth factor-beta1 after transient middle cerebral artery occlusion in rats. Glia 24, — Lenzlinger, P. The duality of the inflammatory response to traumatic brain injury.
Li, F. Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Cell 20, — Li, S. PLoS ONE 8:e Li, T. Li, W. Li, Y. Liang, S. Granulocyte colony-stimulating factor improves neurological function and angiogenesis in intracerebral hemorrhage rats.
Lin, L. Liu, T. Tumor necrosis factor-alpha expression in ischemic neurons. Liu, X. Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia. Lund, H. Fatal demyelinating disease is induced by monocyte-derived macrophages in the absence of TGF-β signaling.
Luo, D. Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis. Malashchenko, V. Direct anti-inflammatory effects of granulocyte colony-stimulating factor G-CSF on activation and functional properties of human T cell subpopulations in vitro.
Malik, A. SorCS2 facilitates release of endostatin from astrocytes and controls post-stroke angiogenesis. Glia 68, — Manoonkitiwongsa, P. Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis.
Marti, H. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Marumo, T. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells.
Diabetes 48, — Maurer, M. Old friends in new constellations—the hematopoetic growth factors G-CSF, GM-CSF, and EPO for the treatment of neurological diseases. Meng, H. LRG1 promotes angiogenesis through upregulating the TGF-β1 pathway in ischemic rat brain.
Menzie-Suderam, J. Granulocyte-colony stimulating factor gene therapy as a novel therapeutics for stroke in a mouse model. Modi, J. Mode of action of granulocyte-colony stimulating factor G-CSF as a novel therapy for stroke in a mouse model.
Muoio, V. The neurovascular unit - concept review. Acta Physiol. Nakamura, K. Possible involvement of basic FGF in the upregulation of PDGFRβ in pericytes after ischemic stroke. Nossent, A. Heart Assoc. Oladipupo, S. Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis.
Olofsson, B. Genomic organization of the mouse and human genes for vascular endothelial growth factor B VEGF-B and characterization of a second splice isoform. Oyamada, N. The role of mineralocorticoid receptor expression in brain remodeling after cerebral ischemia.
Endocrinology , — Pan, J. Hypoxic tissues are associated with microvessel density following brain ischemia-reperfusion. Papapetropoulos, A. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.
Patra, K. Biofactors 45, — Pham, L. Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury. Glia 60, — Potente, M.
Basic and therapeutic aspects of angiogenesis. Pulous, F. Talin-dependent integrin activation is required for endothelial proliferation and postnatal angiogenesis. Angiogenesis 24, — Qin, C. Fingolimod protects against ischemic white matter damage by modulating microglia toward M2 polarization via STAT3 pathway.
Stroke 48, — Ramsauer, M. Getting Tie 2 d up in angiogenesis. Reitmeir, R. Vascular endothelial growth factor induces contralesional corticobulbar plasticity and functional neurological recovery in the ischemic brain. Ribatti, D. Cross talk between natural killer cells and mast cells in tumor angiogenesis.
Roberts, A. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Rustenhoven, J. Brain pericytes as mediators of neuroinflammation. Trends Pharmacol. Saha, P.
TNF-α Tumor Necrosis Factor-α. Salmeron, K. IL-1alpha induces angiogenesis in brain endothelial cells in vitro: implications for brain angiogenesis after acute injury.
Saoud, H. Protective effect of the MCP-1 gene haplotype against schizophrenia. Schierling, W. Increased intravascular flow rate triggers cerebral arteriogenesis. Schmidt, R. Vascular risk factors in dementia. Seledtsov, V. Directs effects of granulocyte-macrophage colony stimulating factor GM-CSF on adaptive immunogenesis.
Shang, J. Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion. Shang, K. Fingolimod promotes angiogenesis and attenuates ischemic brain damage via modulating microglial polarization.
Shyu, W. Sowa, K. Methods Clin. Stapor, P. Pericyte dynamics during angiogenesis: new insights from new identities. Stockmann, C. Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Sugano, M. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia.
Takahashi, H. Taoufik, E. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury.
Uemura, M. Brain microvascular pericytes in vascular cognitive impairment and dementia. Aging Neurosci. Umehara, K. A new conditionally immortalized human fetal brain pericyte cell line: establishment and functional characterization as a promising tool for human brain pericyte studies.
van Weel, V. Vincze, C. Virgintino, D. An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis. Angiogenesis 10, 35— Walshe, T. TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature.
PLoS ONE 4:e Wang, L. Tumor necrosis factor α primes cerebral endothelial cells for erythropoietin-induced angiogenesis. Wang, Y. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena.
Brain , 52— Wang, Z. bFGF protects against blood-brain barrier damage through junction protein regulation via PI3K-Akt-Rac1 pathway following traumatic brain injury. Watari, K. The antitumor effect of a novel angiogenesis inhibitor an octahydronaphthalene derivative targeting both VEGF receptor and NF-κB pathway.
Cancer , — Werner, G. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease. Circulation e; author reply e Wilde, G. Attenuation and augmentation of ischaemia-related neuronal death by tumour necrosis factor-alpha in vitro.
Winkler, E. Central nervous system pericytes in health and disease. Xia, Y. Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3-dependent autophagy in ischemic stroke.
Stem Cell Res. Xu, Q. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 24, — Yang, S. Diverse functions and mechanisms of pericytes in ischemic stroke.
Yao, H. Hyperforin promotes post-stroke neuroangiogenesis via astrocytic ilmediated negative immune regulation in the ischemic brain. Yin, X.
Vascular endothelial growth factor VEGF as a vital target for brain inflammation during the COVID outbreak. ACS Chem. Yuan, H. Zhang, H. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU Zhang, J.
Mechanism of angiogenesis promotion with Shexiang Baoxin Pills by regulating function and signaling pathway of endothelial cells through macrophages. Atherosclerosis , 99— Zhang, K. Role of MCP-1 and CCR2 in alcohol neurotoxicity.
Zhong, M. TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer. Zhou, W. FGF-receptor substrate 2 functions as a molecular sensor integrating external regulatory signals into the FGF pathway.
Cell Res. Zhou, Y. Zhu, J. Berberine facilitates angiogenesis against ischemic stroke through modulating microglial polarization via AMPK signaling.
Zhu, Y. Beta 2 -adrenoceptor stimulation enhances latent transforming growth factor-beta-binding protein-1 and transforming growth factor-beta1 expression in rat hippocampus after transient forebrain ischemia.
Zhu, Z. Serum hepatocyte growth factor is probably associated with 3-month prognosis of acute ischemic stroke. Stroke 49, — Zou, Y. Non-mitogenic fibroblast growth factor 1 enhanced angiogenesis following ischemic stroke by regulating the sphingosinephosphate 1 pathway.
Citation: Zhu H, Zhang Y, Zhong Y, Ye Y, Hu X, Gu L and Xiong X Inflammation-Mediated Angiogenesis in Ischemic Stroke. Angiogenin is a heparin-binding kDa plasma protein with angiogenic and ribonucleolytic activity. Although its structural features have been extensively studied, an understanding of its physiological role and of how its properties are expressed continues to elude researchers.
It has been suggested that angiogenin first binds to actin, followed by dissociation of the actin-angiogenin complex and subsequent activation of tissue plasminogen activator. This generates plasmin, which is known to degrade basement membrane laminin and fibronectin.
The recently discovered Ang-1 and Ang-2 have been clarified to act alongside VEGF. Ang-2 is especially responsible for the initiation of angiogenesis through recruitment and proliferation of ECs. It plays a modulatory role by binding to the Tie-2 receptor. Ang-2 expression can be upregulated by VEGF, bFGF, and hypoxia and can be downregulated by Ang-1 and TGF-β and in an autocrine way by itself.
Several different MMPs are produced by ECs and are strongly implicated in the process of angiogenesis. The activity of MMPs is regulated by inhibitors known as TIMPs, which bind to and inhibit all activated MMPs.
The expression of MMPs and TIMPs is low or absent in healthy tissues but they are upregulated in sites of physiological or pathological angiogenesis. Integrins, chemokines, and adhesion molecules are key players in angiogenesis.
Some integrins αvβ3 and αvβ5 are more involved than others, although they are not specific for neovascularization. Chemokines are also fundamental participants, along with a variety of other factors, that regulate angiogenesis. Within the CXC family of chemokines, there is a functional discrepancy in which some family members are angiogenic and others are angiostatic.
CD also known as MUC18, Mel-CAM, S-Endo, and A32 antigen is a member of the immunoglobulin gene superfamily 79 that functions as an adhesion molecule involved in cell-cell interactions.
It is expressed on ECs, pericytes, and smooth muscle cells. Evidence that angiogenesis is involved in IBD was obtained from animal models of colitis, most notably from studies of angiogenesis inhibition.
Plasma levels of HGF increased significantly after development of acute colitis in mice by acetic acid administration. Colonic FGF binding activity of heparin has been found to be increased in a model of experimental colitis.
Recent experimental data showed that bone marrow is involved in the repair and formation of blood vessels in animal models of colitis, forming ECs, vascular smooth muscle cells, and pericytes. There is evidence that microvascular anatomy in the chronically inflamed intestine, mainly in Crohn's disease CD , has undergone vascular remodeling.
It could be hypothesized that angiogenesis starts early in the course of IBD, similar to other chronic inflammatory diseases, 6 , 93 , 94 and it may antedate the specific clinical and histological signs of inflammation.
At a latter stage, angiogenesis could contribute to the perpetuation of inflammatory manifestations. However, protective factors are thought to mediate the ability of the intestinal mucosa to resist injury and regenerate ulcerated areas. In this context, angiogenesis plays an important role as a protective factor during the regeneration process of injured tissues.
The balance between proangiogenic and antiangiogenic mediators may be critical in restoring recirculation in the inflammatory bowel by promoting neovascularization. EC proliferation is required for sustained angiogenesis.
Studies on intestinal biopsies from patients with IBD have shown alterations of endothelial adhesion molecules. There have been a number of important papers published recently that provide evidence that angiogenesis may be a primary pathogenic mechanism in IBD.
The focus of these studies has been on the regulation of expression of mediators of angiogenesis, in addition to receptor activation and signal transduction pathways. Among angiogenesis markers in IBD, VEGF is the most thoroughly described factor.
Several studies have shown elevated circulating VEGF levels in patients with IBD compared to healthy controls HC.
VEGF production by peripheral blood mononuclear cells of patients with IBD was found to be significantly increased in both active CD and UC.
Inflamed mucosa of patients with active UC or CD showed a significantly higher spontaneous production of VEGF than normal mucosa of HC. VEGF was recently found to induce epithelial cell migration in CACO-2 and IEC cells compared with controls, suggesting that VEGF apart from angiogenesis is also an important factor for intestinal epithelial cell restitution.
IL-4 has been shown to reduce the increased VEGF production of peripheral blood mononuclear cells in patients with IBD to normal levels. Corticosteroids have been found to suppress nonstimulated VEGF production in patients with IBD. The administration of the anti-TNF-α antibody infliximab seems to interfere with VEGF production.
A significant reduction of VEGF levels in the sera of patients with rheumatoid arthritis or psoriasis after intravenous infusions of infliximab has been reported.
Whether therapeutic reduction of serum VEGF levels is indeed associated with inhibition of angiogenesis should be evaluated in future studies.
Thalidomide, which is a potent inhibitor of angiogenesis, has been reported to be effective in refractory and steroid-dependent CD, , as well as in severe therapy-resistant intestinal bleeding related to CD and bleeding of obscure origin. PDGF is overexpressed in inflamed colonic mucosa, predominantly in macrophages and fibroblasts.
In areas of active inflammation and in areas of active fibrosis activated cells positive for mRNA and protein of PDGF-A, -B, -alphaR, and -betaR were found, suggesting that PDGF plays a role in neovascularization in acute inflammation and in the repair process of IBD.
Serum levels of bFGF were significantly higher in active IBD compared to HC. In another study the number of bFGF-containing cells was significantly increased in patients with active IBD compared with patients with IBD in remission. The bFGF levels were lower in patients who responded or who were completely healed with infliximab when compared with patients who did not respond or heal.
In another study, a significant reduction of bFGF serum levels in patients with CD who responded to infliximab therapy was demonstrated. Serum levels of HGF were elevated in patients with IBD compared with HC. Moreover, in this study the serum levels of HGF were directly correlated with disease activity.
These observations suggest that the HGF-Met system is involved in the repair process of the inflamed mucosa of UC. Serum angiogenin levels were found significantly increased in patients with UC and CD compared with HC, but serum angiogenin concentration was not associated with disease activity.
These data suggest that angiogenin in IBD patients may act as a mediator of the effects of inflammation, but it may also have a more prominent role in the reconstruction of damaged mucosa in UC and CD.
There are no studies of angiogenin in the gut tissues of patients with IBD, which are needed to delineate the role of angiogenin in wound healing.
Serum Ang-2 and its receptor Tie-2 levels were significantly increased in patients with UC and CD compared with HC. The local levels of these mediators in the intestine where angiogenesis occurs and the precise source or stimuli for the overproduction of these molecules in IBD remain obscure.
MMPs, such as MMP-1, MMP-9, and TIMP-1, which are involved in tissue remodeling, are expressed by vascular smooth muscle cells of venules in ulcer bases of patients with IBD. These results suggest that MMPs may play an important role in angiogenesis in IBD.
A role of CD, a transmembrane glycoprotein expressed at the junction of ECs, which is involved in the control of cell-cell cohesion and in angiogenesis has recently been suggested in IBD.
In addition, a decrease of sCD in active and extensive disease in both CD and UC was observed. These findings could indicate a mechanism of active angiogenesis and altered vascular permeability in IBD.
Angiogenesis is enhanced in IBD and is 1 component of the increased vascular turnover observed during active disease. Our assessment of the evidence led to the conclusion that angiogenesis may contribute to the initiation and perpetuation of IBD.
Future studies should address the specific pathways that mediate pathological angiogenesis in IBD. Angiogenesis in IBD is a complex process rather than a single entity, and our increasing understanding of the various roles of intestinal vascular growth raises the exciting possibility of novel therapeutic strategies in IBD.
Targeting angiogenesis in IBD in the future may provide additional benefits when used in combination with current treatments, the main goal of which is to combat inflammation.
Risau W. Mechanisms of angiogenesis. Google Scholar. Dvorak HF. Angiogenesis: update J Thromb Haemost. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease.
Nat Med. Carmeliet P. Angiogenesis in health and disease. Angiogenesis in life, disease and medicine. Clavel G , Bessis N , Boissier MC. Recent data on the role for angiogenesis in rheumatoid arthritis.
Joint Bone Spine. Simons M. Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed? J Am Coll Cardiol. Angiogenesis: where do we stand now? Walsh DA. Angiogenesis and arthritis. Rheumatology Oxford. Walsh DA , Pearson CI.
Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res. Ferrara N , Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Qu Z , Liebler JM , Powers MR , et al.
Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol. Taylor PC , Sivakumar B. Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol. Hatton MW , Southward SM , Legault KJ , et al.
Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: effluxing fibrin ogen fragments contain antiangiogenic activity. J Lab Clin Med. Cullen JP , Sayeed S , Sawai RS , et al. Pulsatile flow-induced angiogenesis: role of G i subunits.
Arterioscler Thromb Vasc Biol. Schaper W , Scholz D. Factors regulating arteriogenesis. Hatoum OA , Binion DG , Gutterman DD.
Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease. Eur J Clin Invest. Di Sabatino A , Fulle I , Ciccocioppo R , et al.
Doppler enhancement after intravenous levovist injection in Crohn's disease. Inflamm Bowel Dis. Griga T , Tromm A , Spranger J , et al. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease.
Scand J Gastroenterol. Griga T , Voigt E , Gretzer B , et al. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Kanazawa S , Tsunoda T , Onuma E , et al. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol. Griga T , May B , Pfisterer O , et al. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Di Sabatino A , Ciccocioppo R , Armellini E , et al. Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn's disease. Konno S , Iizuka M , Yukawa M , et al.
Altered expression of angiogenic factors in the VEGF-Ets-1 cascades in inflammatory bowel disease. J Gastroenterol. Koutroubakis IE , Xidakis C , Karmiris K , et al. Serum angiogenin in inflammatory bowel disease. Dig Dis Sci. Potential role of soluble angiopoietin-2 and tie-2 in patients with inflammatory bowel disease.
Danese S , Sans M , Beck I , et al. Starving the inflamed gut: angiogenesis blockade as a novel approach to experimental colitis. Jackson JR , Seed MP , Kircher CH , et al. The codependence of angiogenesis and chronic inflammation. FASEB J. Puxeddu I , Ribatti D , Crivellato E , et al.
Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol. Fajardo LF , Kwan HH , Kowalski J , et al. Dual role of tumor necrosis factor-alpha in angiogenesis. Nagashima M , Yoshino S , Ishiwata T , et al.
Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol. Peacock DJ , Banquerigo ML , Brahn E. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis.
Cell Immunol. Storgard CM , Stupack DG , Jonczyk A , et al. Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest. Salcedo X , Medina J , Sanz-Cameno P , et al.
Review article: angiogenesis soluble factors as liver disease markers. Aliment Pharmacol Ther. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
Semin Oncol. Nash AD , Baca M , Wright C , et al. The biology of vascular endothelial growth factor-B VEGF-B. Pulm Pharmacol Ther. Neufeld G , Cohen T , Shraga N , et al. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med.
Milkiewicz M , Ispanovic E , Doyle JL et al Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol. Costa C , Soares R , Schmitt F. Angiogenesis: now and then.
Zachary I. VEGF signaling: integration and multi-tasking in endothelial cell biology. Biochem Soc Trans. Schoppmann SF.
Athlete bone health support, D. Angiogenesis and inflzmmation are Angilgenesis integrated processes Athlete bone health support osteoarthritis OA and may affect disease progression Plyometric exercises pain. Inflammation can stimulate angiogenesis, and angiogenesis can facilitate inflammation. Angiogenesis can also promote chondrocyte hypertrophy and endochondral ossification, contributing to radiographic changes in the joint. Inflammation sensitizes nerves, leading to increased pain.
0 thoughts on “Angiogenesis and inflammation”